Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Türedi, SÜLEYMAN; Gündüz, ABDÜLKADİR; Menteşe, AHMET; Dasdibi, Bengu; Karahan, SÜLEYMAN; Sahin, AYNUR; Tuten, Gamze; Kopuz, Muge; Alver, AHMET

doi:10.1016/j.resuscitation.2009.06.007

Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Türedi S., Gündüz A., Menteşe A., Dasdibi B., Karahan S. C., Sahin A., ...Daha Fazla

RESUSCITATION, cilt.80, sa.9, ss.994-999, 2009 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 80 Sayı: 9
Basım Tarihi: 2009
Doi Numarası: 10.1016/j.resuscitation.2009.06.007
Dergi Adı: RESUSCITATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.994-999
Anahtar Kelimeler: Ischemia-modified albumin, Ischemia, Cardiac arrest, Cardiopulmonary resuscitation, Oxidative stress, NEURON-SPECIFIC ENOLASE, PULMONARY-EMBOLISM, OXIDATIVE STRESS, SERUM, DIAGNOSIS, HYPOTHERMIA, PREDICTION, PROTEIN, S-100, COMA
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: Early and accurate prediction of survival to hospital discharge following resuscitation after cardiac arrest (CA) is a major challenge. Our aim was to investigate the levels of ischemia-modified albumin (IMA) and malondialdehyde (MDA) in CA patients and whether IMA levels are valuable early marker of post-cardiopulmonary resuscitation prognosis in CA patients.